Depomed to Present at the UBS Global Healthcare Conference
May 16 2017 - 4:02PM
Depomed, Inc. (NASDAQ:DEPO) today announced that members of senior
management will participate in a fireside chat at the 2017 UBS
Global Healthcare Conference scheduled for 10:00 am ET (7:00 am PT)
on Tuesday, May 23, 2017 in New York, New York.
This presentation will be webcast and can be accessed via the
Investor Relations page of the Depomed website at
www.depomed.com. A recording of the webcasts will be archived
for 30 days.
About Depomed
Depomed is a leading specialty pharmaceutical company focused on
enhancing the lives of the patients, families, physicians,
providers and payors we serve through commercializing innovative
products for pain and neurology related disorders. Depomed markets
six medicines with areas of focus that include mild to severe acute
pain, moderate to severe chronic pain, neuropathic pain, migraine
and breakthrough cancer pain. Depomed is headquartered in Newark,
California. To learn more about Depomed, visit www.depomed.com.
Investor Contact:
Christopher Keenan
VP, Investor Relations and Corporate Communications
510-744-8000
ckeenan@depomed.com
Depomed, Inc. (delisted) (NASDAQ:DEPO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Depomed, Inc. (delisted) (NASDAQ:DEPO)
Historical Stock Chart
From Sep 2023 to Sep 2024